Kairos Pharma, LTD. Quarterly Common Stock, Par or Stated Value Per Share in USD/shares from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
Face amount or stated value per share of common stock.
Summary
Kairos Pharma, LTD. quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q1 2023 to Q3 2024.
  • Kairos Pharma, LTD. Common Stock, Par or Stated Value Per Share for the quarter ending September 30, 2024 was 0 USD/shares.
Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.